Related Experiment Video
Updated: Jun 27, 2026
07:29
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Integrating biologically targeted therapy in head and neck squamous cell carcinomas
1Department of Radiation Oncology, Stanford University, Stanford, CA 94305-5847, USA. qle@stanford.edu
Seminars in Radiation Oncology
|November 26, 2008
Summary
Targeted therapies like cetuximab are revolutionizing head and neck cancer treatment. This review addresses key questions regarding their optimal use, integration, and future development in radiation therapy.
Area of Science:
- Oncology
- Radiation Oncology
- Cancer Therapy
Background:
- Targeted therapies, including cetuximab, have significantly advanced head and neck cancer management.
- Their integration with radiation therapy presents complex clinical questions requiring further investigation.
Purpose of the Study:
- To review critical unanswered questions in the clinical application of targeted therapies for head and neck cancers.
- To discuss ongoing clinical trials addressing these issues and explore novel targeted treatments.
Main Methods:
- Literature review of current research and clinical trials.
- Analysis of key questions regarding patient selection, treatment optimization, and toxicity.
- Introduction of emerging targeted therapies.
Main Results:
- Identified key clinical questions: optimal patient/tumor profiles, radiation fractionation, integration with chemoradiation, scheduling, duration, and toxicity.
- Highlighted the importance of ongoing clinical trials to answer these questions.
- Presented novel targeted therapies with potential to improve therapeutic ratios.
Conclusions:
- Optimizing the use of targeted therapies in head and neck cancer requires addressing several critical clinical questions.
- Further research and clinical trials are essential for refining treatment strategies and improving patient outcomes.
- Novel targeted therapies hold promise for enhancing the efficacy and safety of head and neck cancer treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...